182 related articles for article (PubMed ID: 21458210)
1. [Intestinal non-Hodgkin lymphoma: "immunoproliferative small intestinal disease"].
Mrabti H; Raiss G; Raissouni S; Tazi el M; Inghaouen H; El Ghissassi I; Errihani H
Presse Med; 2011 Nov; 40(11):995-1000. PubMed ID: 21458210
[TBL] [Abstract][Full Text] [Related]
2. Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms.
Al-Saleem T; Al-Mondhiry H
Blood; 2005 Mar; 105(6):2274-80. PubMed ID: 15542584
[TBL] [Abstract][Full Text] [Related]
3. Immunoproliferative small intestinal disease associated with Campylobacter jejuni.
Lecuit M; Abachin E; Martin A; Poyart C; Pochart P; Suarez F; Bengoufa D; Feuillard J; Lavergne A; Gordon JI; Berche P; Guillevin L; Lortholary O
N Engl J Med; 2004 Jan; 350(3):239-48. PubMed ID: 14724303
[TBL] [Abstract][Full Text] [Related]
4. Heavy Chain Disease of the Small Bowel.
Bianchi G; Sohani AR
Curr Gastroenterol Rep; 2018 Jan; 20(1):3. PubMed ID: 29372346
[TBL] [Abstract][Full Text] [Related]
5. Primary small-intestinal lymphomas in Taiwan: immunoproliferative small-intestinal disease and nonimmunoproliferative small-intestinal disease.
Shih LY; Liaw SJ; Dunn P; Kuo TT
J Clin Oncol; 1994 Jul; 12(7):1375-82. PubMed ID: 8021727
[TBL] [Abstract][Full Text] [Related]
6. Roles of syndecan-1, bcl6 and p53 in diagnosis and prognostication of immunoproliferative small intestinal disease.
Vaiphei K; Kumari N; Sinha SK; Dutta U; Nagi B; Joshi K; Singh K
World J Gastroenterol; 2006 Jun; 12(22):3602-8. PubMed ID: 16773719
[TBL] [Abstract][Full Text] [Related]
7. MALT lymphoma of the small bowel with protein-losing enteropathy.
Tsukamoto A; Nakamura F; Nannya Y; Kobayashi Y; Shibahara J; Ichikawa M; Fukayama M; Koike K; Kurokawa M
Int J Hematol; 2014 Feb; 99(2):198-201. PubMed ID: 24395281
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological features and management of immunoproliferative small intestinal disease and primary small intestinal lymphoma in Pakistan.
Malik IA; Shamsi Z; Shafquat A; Aziz Z; Shaikh H; Jafri W; Khan MA; Khan AH
Med Pediatr Oncol; 1995 Nov; 25(5):400-6. PubMed ID: 7674998
[TBL] [Abstract][Full Text] [Related]
9. A mucosa-associated lymphoid tissue (MALT) lymphoma of the small intestine that was difficult to diagnose endoscopically.
Yoneda K; Takahashi H; Abe Y; Inamori M; Kato S; Uchiyama T; Iida H; Mawatari H; Hosono K; Endo H; Nozaki Y; Akiyama T; Fujita K; Yoneda M; Kobayashi N; Kirikoshi H; Kubota K; Saito S; Nakajima A
Endoscopy; 2010; 42 Suppl 2():E175. PubMed ID: 20560120
[No Abstract] [Full Text] [Related]
10. Treatment of gastric marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue with rituximab, cyclophosphamide, vincristine and prednisone.
Aguiar-Bujanda D; Llorca-Mártinez I; Rivero-Vera JC; Blanco-Sánchez MJ; Jiménez-Gallego P; Mori-De Santiago M; Limeres-Gonzalez MA; Cabrera-Marrero JC; Hernández-Sosa M; Galván-Ruíz S; Hernández-Sarmiento S; Saura Grau S; Bohn-Sarmiento U
Hematol Oncol; 2014 Sep; 32(3):139-44. PubMed ID: 24123108
[TBL] [Abstract][Full Text] [Related]
11. [Alpha-heavy chain disease--Mediterranean lymphoma].
Kaufmann HP; Schmitt W; Seib HJ
Leber Magen Darm; 1994 Feb; 24(1):32-5. PubMed ID: 8145624
[TBL] [Abstract][Full Text] [Related]
12. [Primary immunoproliferative small intestinal disease].
Nardulli Fernández G; Sukerman V; Marsicano L; Ramón Poleo JR; Hernández D; Almosny I; Olavarría R
G E N; 1995; 49(3):238-42. PubMed ID: 8598264
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathologic features of primary thymic extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type].
Sun L; Shi HY; Wei LX
Zhonghua Bing Li Xue Za Zhi; 2012 Apr; 41(4):234-8. PubMed ID: 22800518
[TBL] [Abstract][Full Text] [Related]
14. Five-year results of the treatment of 23 patients with immunoproliferative small intestinal disease: a Turkish experience.
Akbulut H; Soykan I; Yakaryilmaz F; Icii F; Aksoy F; Haznedaroglu S; Yildirim S
Cancer; 1997 Jul; 80(1):8-14. PubMed ID: 9210703
[TBL] [Abstract][Full Text] [Related]
15. Malabsorption associated with a high-grade-malignant non-Hodgkin's lymphoma, alpha-heavy-chain disease and immunoproliferative small intestinal disease.
Hubmann R; Kaiser W; Radaszkiewicz T; Fridrik M; Zazgornik I
Z Gastroenterol; 1995 Apr; 33(4):209-13. PubMed ID: 7793120
[TBL] [Abstract][Full Text] [Related]
16. [Immunoproliferative small intestinal disease (IPSID): an unusual form of gastrointestinal lymphoma].
Zahner J; Kirchner T; Ott G; Schneider W
Schweiz Med Wochenschr; 1994 Jul; 124(27-28):1227-31. PubMed ID: 8052827
[TBL] [Abstract][Full Text] [Related]
17. Campylobacter coli cultured from the stools of a patient with immunoproliferative small intestinal disease.
Coeuret S; de La Blanchardière A; Saguet-Rysanek V; Chèze S; Tavernier M; Arsène D; Criscuolo A; Brisse S; Vergnaud M; Verdon R; Lecuit M
Clin Microbiol Infect; 2014 Sep; 20(9):908-11. PubMed ID: 24438451
[TBL] [Abstract][Full Text] [Related]
18. Immunoproliferative small intestinal disease in South India: a clinical and immunomorphological study.
Nair S; Mathan M; Ramakrishna BS; Mathan VI
J Gastroenterol Hepatol; 1998 Dec; 13(12):1207-11. PubMed ID: 9918427
[TBL] [Abstract][Full Text] [Related]
19. A case of mucosa-associated lymphoid tissue lymphoma forming multiple lymphomatous polyposis in the small intestine.
Hirata N; Tominaga K; Ohta K; Kadouchi K; Okazaki H; Tanigawa T; Shiba M; Watanabe T; Fujiwara Y; Nakamura S; Oshitani N; Higuchi K; Arakawa T
World J Gastroenterol; 2007 Mar; 13(9):1453-7. PubMed ID: 17457982
[TBL] [Abstract][Full Text] [Related]
20. A retrospective analysis of primary gastric diffuse large B-cell lymphoma with or without concomitant mucosa-associated lymphoid tissue (MALT) lymphoma components.
Li X; Xia B; Guo S; Zhan Z; Zhang L; Zhao D; Wu X; Zhang Y
Ann Hematol; 2013 Jun; 92(6):807-15. PubMed ID: 23417758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]